Clinical Trials in Brentwood, Tennessee
10 recruiting
Showing 1–9 of 9 trials
Recruiting
Not Applicable
The PEERLESS II Study
Pulmonary Embolism
Inari Medical1,200 enrolled83 locationsNCT06055920
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
Stryker Instruments8,000 enrolled2262 locationsNCT03072927
Recruiting
Phase 3
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more
Novartis Pharmaceuticals220 enrolled15 locationsNCT06858319
Recruiting
Not Applicable
Vanderbilt Integrated Community TMS for Opioid Recovery
Opiod Use Disorder
Vanderbilt University Medical Center100 enrolled2 locationsNCT07457489
Recruiting
Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Shanghai Henlius Biotech246 enrolled51 locationsNCT07176650
Recruiting
Not Applicable
The Fourth Left Atrial Appendage Occlusion Study
Atrial FibrillationStroke, IschemicSystemic Embolism
Hamilton Health Sciences Corporation4,000 enrolled127 locationsNCT05963698
Recruiting
Not Applicable
Galleri® in the Medicare Population.
Cancer
GRAIL, Inc.50,000 enrolled47 locationsNCT05673018
Recruiting
Not Applicable
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Treatment Resistant Depression
LivaNova6,800 enrolled98 locationsNCT03887715
Recruiting
Not Applicable
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
Long COVID
MaxWell Clinic, PLC224 enrolled3 locationsNCT06311435